Is HUMDF or MRK a better dividend investment in 2026?

HUMDF currently yields 484.14% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: HUMDF offers higher current income.

What is the dividend yield difference between HUMDF and MRK?

HUMDF has a forward dividend yield of 484.14% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 481.38 percentage points.

Home › Compare › HUMDF vs MRK

HUMDF vs MRK: Dividend Comparison 2026

HUMDF yields 484.14% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HUMDF wins by $47899.95M in total portfolio value

INVESTMENT

TIME HORIZON10 years

HUMDF

● Live price

484.14%

Share price

$0.41

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$47900.01M

Annual income

$34,060,653,223.60

Full HUMDF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — HUMDF vs MRK

📍 HUMDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HUMDF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HUMDF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HUMDF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HUMDF

Annual income on $10K today (after 15% tax)

$41,152.26/yr

After 10yr DRIP, annual income (after tax)

$28,951,555,240.06/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, HUMDF beats the other by $28,951,546,911.65/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HUMDF + MRK for your $10,000?

HUMDF: 50%MRK: 50%

100% MRK50/50100% HUMDF

Portfolio after 10yr

$23950.03M

Annual income

$17,030,331,510.87/yr

Blended yield

71.11%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

HUMDF

No analyst data

Altman Z

3.9

Piotroski

5/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HUMDF buys

MRK buys

No recent congressional trades found for HUMDF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHUMDFMRK

Forward yield	484.14% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$47900.01M ✓	$56.8K
Annual income after 10y	$34,060,653,223.60 ✓	$9,798.13
Total dividends collected	$46687.76M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: HUMDF vs MRK ($10,000, DRIP)

Year	HUMDF Portfolio	HUMDF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$59,114	$48,414.43	$11,206	$366.19	+$47.9K → HUMDF
2	$330,728	$267,475.81	$12,650	$502.35	+$318.1K → HUMDF
3	$1,752,431	$1,398,551.73	$14,407	$694.19	+$1.74M → HUMDF
4	$8,800,812	$6,925,711.29	$16,585	$967.82	+$8.78M → HUMDF
5	$41,922,789	$32,505,919.38	$19,342	$1,363.89	+$41.90M → HUMDF
6	$189,569,894	$144,712,509.91	$22,913	$1,947.19	+$189.55M → HUMDF
7	$814,403,207	$611,563,420.90	$27,662	$2,823.89	+$814.38M → HUMDF
8	$3,326,842,984	$2,455,431,552.18	$34,159	$4,173.35	+$3326.81M → HUMDF
9	$12,933,979,587	$9,374,257,594.32	$43,337	$6,308.80	+$12933.94M → HUMDF
10	$47,900,011,382	$34,060,653,223.60	$56,776	$9,798.13	+$47899.95M → HUMDF

HUMDF vs MRK: Complete Analysis 2026

HUMDF — Stock

Hua Medicine (Shanghai) Ltd. operates as a clinical-stage drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin that is in Phase I clinical trial for treatment of T2D. The company also offers Dorzagliatin in combination with Pioglitazone for NASH; in combination with GLP-1 for Alzheimer diseases; and in combination with late stage T2D and Type 1 Diabetes. In addition, it is developing mGLUR5 for the treatment of Parkinson's disease levodopa-induced dyskinesia. The company was incorporated in 2011 and is based in Beijing, China.

Full HUMDF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this HUMDF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HUMDF vs SCHD HUMDF vs JEPI HUMDF vs O HUMDF vs KO HUMDF vs MAIN HUMDF vs JNJ HUMDF vs ABBV HUMDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.